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Abstract: 
Lyme disease is an infectious disease caused by a spirochete Borrelia burgdorferi ZS7. This spirochete is most often spread by ticks. Single antibiotic therapy is 
sufficient for containment of the early stage progression of the disease but combinational therapy is more preferred in later stages. Research is in progress for the 
development of drugs against the pathogen, but till date no vaccines have been developed to effect the late stage infections. There is a rapid rise in the cases of 
antibiotic-resistant population which is more than 10% of the total infected individuals. In such condition vaccine becomes the sole alternative for prevention. 
Therefore effective treatment includes antibiotic combination and combination of antigenic surfaces (for vaccine preparation). Thus, a comprehensive list of drug 
targets unique to the microorganisms is often necessary. Availability of Borrelia burgdorferi ZS7 proteome has enabled insilico analysis of protein sequences for 
the identification of drug targets and vaccine targets. In this study, 272 essential proteins were identified out of which 42 proteins were unique to the 
microorganism. The study identified 15 membrane localized drug targets. Amongst these 15, molecular modeling and structure validation of the five membrane 
localized drug target proteins could only be achieved because of the low sequence identity of the remaining proteins with RCSB structures. These 3D structures 
can be further characterized by invitro and invivo studies for the development of novel vaccine epitopes and novel antibiotic therapy against Borrelia burgdorferi. 
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Background: 
Despite rapid advances in the diagnosis of bacterial infections and the 
availability of effective antibiotics, Lyme disease, the most common vector 
borne disease continues to represent a substantial public health problem for 
most countries like United States and Europe [1]. Borrelia burgdorferi, the 
causative organism is a gram negative, fastidious spirochaete, an obligate 
internal parasite that is vectored between the vertebrate hosts by hard bodied 
ticks of lxodes ricinis complex [2]. It remains in zoonotic cycle for its survival 
in nature since neither the vertebrates nor the vectors can transmit 
B.burgdorferi from one generation to another [3]. In most cases, infection is 
marked by erythema migrans. Other signs of early infection are nonspecific and 
include fever, myalgias, arthralgias, and fatigue [4]. It is a helical-shaped 
bacterium with outer and inner membrane and flexible cell wall. The outer 
membrane proteins are key components in transmission of bacteria [5]. 
Common antibiotic therapy includes tetracycline for the early manifestation 
and high doses of erythromycin and penicillin for children and pregnant 
women [6]. Prevention and cure can be accomplished by vaccine preparation 
involving antigenic surfaces that trigger humoral immune response which has 
long been found to be protective against Borrelia burgdorferi infections [7]. In 
the present study, insilico subtractive genomics approach has been carried out 
to identify non homologous essential membrane proteins of Borrelia 
burgdorferi ZS7. These membrane associated proteins could be effective 
candidates for new vaccine epitope design and for screening of potential anti-
borellioses drugs. 
 
Methodology: 
The essential proteins of Borrelia burgdorferi ZS7 were identified using 
subtractive genomics approach and further analysed for identification of 
potential drug targets [8]. The flow chart describing the detailed methodology 
for identification of pathogen specific essential proteins using subtractive 
genomics approach is shown in Figure 1(a). The complete proteome of 
Borrelia burgdorferi ZS7 was retrieved from NCBI [9]. Each protein sequence 
of the bacteria was subjected to BLAST-P, specifically against DEG (Database 
of Essential Genes) available at http://tubic.tju.edu.cn/deg/ for the screening of 
essential genes [10]. Cut off for E-value, bit score and percentage of identity at 
amino acid level were considered <E-10, >100 and >35% respectively. 
Matches of length <100 amino acids were not considered for further studies. 
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Figure 1(a): Flow chart describing the detailed methodology for identification 
of pathogen specific essential proteins using subtractive genomics approach; 
(b) Comparative Bar Chart between total number of proteins and membrane 
associated essential proteins. 
 
Selection of non homologue essential gene: 
The essential proteins were subjected to human BLASTp in NCBI server. 
Sequences that did not show similarity with any human sequences were 
selected. 
 
Identification of membrane localized candidate drug targets: 
Sub-cellular localization of each identified non homologue essential gene was 
determined by Specialized Sub Cellular Localization Server v2.5 (PA-SUB) 
[11]. 
 
Metabolic Pathway Analysis: 
Metabolic pathway analysis of the essential proteins of Borrelia burgdorferi 
ZS7 was done by KEGG Automatic Annotation Server (KAAS) [12]. 
Comparative analysis of the metabolic pathways of the host and pathogen was 
performed by using Kyoto Encyclopedia of Genes and Genomes (KEGG) 
pathway database for identification of pathogen specific metabolic pathway 
associated proteins. 
 
Homology modeling for 3D structure of putative drug targets: 
Modeling of the target proteins were performed using MODELLER Version 
9.9. A template search has been performed through BLAST and PSI-BLAST 
programs [13]. Global alignment method was used for comparison between the 
target-template sequences [14]. Gaps with variable gap penalty function are 
included for structural loops and core regions, in order to get maximum 
correspondence between the sequences. Alignment file for MODELLER was 
prepared by CLUSTALW [15]. Fold recognition was done through 
GenThreader and LOMETS server for fold assignment [16]. Energy 
minimization of generated 3D-model was done through GROMACS (OPLS 
force field) by using Steepest Descent and Conjugate Gradient Algorithms 
[17]. Parameters like covalent bond distances and angles, stereochemical 
validation, atom nomenclature were validated using PROCHECK and overall 
quality factor of non-bonded interactions between different atoms types were 
measured by ERRAT program [18]. RMSD (root-mean-square deviation) and 
RMSF (Root Mean Square Fluctuation) was calculated for modeled structures. 
Functionally important residues (Active-site) were identified through 
comparative result of POCKETFINDER and SURFACE RACER 4.0. The 
generated 3D model of target proteins was checked by Ramachandran plot 
through PROCHECK program. 
  
Result and Discussion: 
A subtractive genomics approach utilizes the whole proteome of host and 
pathogen to identify proteins exclusively present in the pathogen by deducing 
the homologous proteins [19]. Based on the similar approach as mentioned in 
materials and methods, 272 essential genes in Borrelia burgdorferi genome 
were found to be non homologous to human (putative drug targets). Figure 
1(b) shows the comparative analysis between the total number of proteins to 
the number of essential & membrane bound proteins respectively. These non 
human homologous targets identified were further analysed for sub-cellular 
localization prediction which detected 15 membrane localized proteins. 
Membrane localized proteins represent largest group (70%) of effective drug 
targets in any organism [20] and can also act as potential epitopes for vaccine 
design. Table 1 (see Supplementary material) gives the details of function, 
cellular localization and KEGG biochemical pathways of membrane localized 
proteins of Borrelia burgdorferi ZS7. Modeling was a tedious task due to very 
low sequence similarity and coverage and only five models could be obtained. 
Three dimensional model of drug targets were generated through identified 
templates along with fold fitting. Fold recognization was done through 
GenThreader and LOMETS server for fold assignment. Helices have 
dominance over other secondary structure. Ramachandran plot of all the five 
proteins analysed using PROCHECK with the description of the allowed 
regions are shown in Figure 2. Our results yielded kinases namely   
phosphoglycerate kinase, chemotaxis histidine kinase, that are likely to be 
involved in cell cycle control, differentiation and response to stress during their 
complex life cycle. Kinases have been reported to be the drug targets [21]. In 
our study three of the proteins are penicillin binding proteins, role of these 
proteins as drug targets have also been studied [22]. Preprotein translocase 
plays an important role in extracellular transport and also as drug target [23]. 
ATP-dependent protease La is involved in catalysis of damaged or senescent 
proteins and short-lived regulatory proteins and therefore serves as drug target. 
Although most of the proteins mentioned are not validated as drug targets they 
are putative by virtue of their essentiality using bioinformatics tools and 
deserves further studies. 
 
 
Figure 2: Ramachandran plot of modeled drug targets using PROCHECK (1) 
Preprotein translocase; (2) SecA subunit penicillin-binding protein; (3) UDP-
N-acetylmuramate--alanine ligase; (4) phosphoglycerate kinase; (5) V-type 
ATP synthase subunit; (6) Percentage of amino acids in allowed regions of the 
target proteins.  
 
 
Conclusion: 
The large scale genome sequencing projects have increased the availability of 
completely sequenced genomic and proteomic data in public domain. Use of 
the DEG database is more efficient than conventional methods for 
identification of essential genes and facilitates the exploratory identification of 
the most relevant drug targets in the pathogen. The present study has thus led to 
the identification of several proteins that can be targeted for effective drug BIOINFORMATION  open access 
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design against Borrelia burgdorferi ZS7. The drugs developed against these 
will be specific to the pathogen, and therefore will be less or non toxic to the 
host. Since the number of essential genes in the metabolic pathways of Borrelia 
burgdorferi ZS7, has been identified in the present study, these can be further 
characterized and their role in the survival of the bacteria can be verified. 
Homology modelling of these targets will help identify the best possible sites 
that can be targeted for drug design by simulation modelling. Virtual screening 
against these novel targets might be useful in the discovery of novel therapeutic 
compounds against Borrelia burgdorferi ZS7. 
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Supplementary material: 
 
Table1: Function, Cellular localization and Biochemical pathways of membrane localized proteins in Borelia burgdorferi 
S.No  Accession No  Name of the protein  Cellular 
localization 
Metabolic pathways in pathogen  Metabolic pathways in 
pathogen and not in 
Human 
1 YP_002374587.1  Phosphoglycerate  kinase  Cytoplasmic, 
Outer Membrane 
Glycolysis/ Gluconeogenesis,Carbon 
fixation in photosynthetic organisms 
Carbon fixation in 
photosynthetic organisms 
2  YP_002374621.1  V-type ATP synthase beta chain (V-
type 
ATPase subunitB 
Cytoplasmic, 
Outer Membrane 
Oxidative phosphorylation, 
Methane metabolism 
Methane metabolism 
3  YP_002374664.1  Penicillin-binding protein  Outer Membrane  Peptidoglycan biosynthesis  Peptidoglycan 
biosynthesis 
 
4  YP_002374680.1  Preprotein translocase, SecA subunit  Cytoplasmic, 
Outer Membrane 
Protein export,  Bacterial 
secretion system 
Bacterial secretion 
system 
5 YP_002374728.1  UDP-N-acetylmuramoylalanyl-D-
glutamate--2,6- diaminopimelate 
ligase 
Cytoplasmic, 
Outer Membrane 
Lysine biosynthesis, 
Peptidoglycan 
biosynthesis 
Peptidoglycan 
biosynthesis 
 
6  YP_002374811.1  Flagellar protein export ATPase FliI  Cytoplasmic, 
Outer Membrane 
Flagellar assembly  Flagellar assembly 
7  YP_002375118.1  ATP-dependent protease La  Outer Membrane  Cellcycle Caulobacter  Cellcycle Caulobacter 
8  YP_002375152.1  Protein-export membrane protein 
SecD 
Outer Membrane  Protein export, Bacterial secretion 
system 
Bacterial secretion 
system 
9  YP_002375194.1  Signal recognition particle protein  Outer Membrane  Protein export,Bacterial secretion 
system 
Bacterial secretion 
system 
10  YP_002375216.1  Penicillin-binding protein  Outer Membrane  Peptidoglycan biosythesis  Peptidoglycan 
biosynthesis 
 
11  YP_002375231.1  Penicillin-binding  protein Outer  Membrane  Peptidoglycan  biosynthesis Peptidoglycan 
biosynthesis 
 
12 YP_002375315.1  UDP-N-acetylmuramate--alanine 
ligase 
Cytoplasmic, 
Outer Membrane 
D-glutamine and D- 
glutamatemetabolism, 
Peptidoglycan biosynthesis 
Cellcycle Caulobacter 
13 YP_002374928.1  Chemotaxis  protein  methyltransferase  Cytoplasmic, 
Outer Membrane 
Two-component system, Bacterial 
chemotaxis 
Two-component system, 
Bacterial chemotaxis 
14  YP_002375074.1  Chemotaxis histidine kinase  Outer Membrane  Two-component system, Bacterial 
chemotaxis 
Two-component system, 
Bacterial chemotaxis 
15  YP_002375181.1  Methyl-accepting chemotaxis protein  Outer Membrane  Two-component system, Bacterial 
chemotaxis 
Two-component system, 
Bacterial chemotaxis 
 